These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 8724521

  • 1. Automated determination of the left ventricular long axis in cardiac positron tomography.
    deKemp RA, Nahmias C.
    Physiol Meas; 1996 May; 17(2):95-108. PubMed ID: 8724521
    [Abstract] [Full Text] [Related]

  • 2. A procedure for wall detection in [18F]FDG positron emission tomography heart studies.
    Landoni C, Bettinardi V, Lucignani G, Gilardi MC, Striano G, Fazio F.
    Eur J Nucl Med; 1996 Jan; 23(1):18-24. PubMed ID: 8586097
    [Abstract] [Full Text] [Related]

  • 3. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability.
    Baer FM, Voth E, Schneider CA, Theissen P, Schicha H, Sechtem U.
    Circulation; 1995 Feb 15; 91(4):1006-15. PubMed ID: 7850935
    [Abstract] [Full Text] [Related]

  • 4. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL.
    Circulation; 1991 Jan 15; 83(1):26-37. PubMed ID: 1984883
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis of myocardial viability by dual-head coincidence gamma camera fluorine-18 fluorodeoxyglucose positron emission tomography with and without non-uniform attenuation correction.
    Nowak B, Zimny M, Schwarz ER, Kaiser HJ, Schaefer W, Reinartz P, vom Dahl J, Buell U.
    Eur J Nucl Med; 2000 Oct 15; 27(10):1501-8. PubMed ID: 11083539
    [Abstract] [Full Text] [Related]

  • 6. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization.
    Baer FM, Voth E, Deutsch HJ, Schneider CA, Horst M, de Vivie ER, Schicha H, Erdmann E, Sechtem U.
    J Am Coll Cardiol; 1996 Jul 15; 28(1):60-9. PubMed ID: 8752795
    [Abstract] [Full Text] [Related]

  • 7. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.
    Knuuti MJ, Saraste M, Nuutila P, Härkönen R, Wegelius U, Haapanen A, Bergman J, Haaparanta M, Savunen T, Voipio-Pulkki LM.
    Am Heart J; 1994 Apr 15; 127(4 Pt 1):785-96. PubMed ID: 8154416
    [Abstract] [Full Text] [Related]

  • 8. Issues in the quantitation of reoriented cardiac PET images.
    Kuhle WG, Porenta G, Huang SC, Phelps ME, Schelbert HR.
    J Nucl Med; 1992 Jun 15; 33(6):1235-42. PubMed ID: 1597745
    [Abstract] [Full Text] [Related]

  • 9. Cardiac phantom measurement validating the methodology for a cardiac multi-centre trial with positron emission tomography.
    Nuyts J, Mortelmans L, Van de Werf F, Djian J, Sambuceti G, Schwaiger M, Touboul P, Maes A.
    Eur J Nucl Med Mol Imaging; 2002 Dec 15; 29(12):1588-93. PubMed ID: 12458392
    [Abstract] [Full Text] [Related]

  • 10. Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography.
    Nekolla SG, Miethaner C, Nguyen N, Ziegler SI, Schwaiger M.
    Eur J Nucl Med; 1998 Sep 15; 25(9):1313-21. PubMed ID: 9724382
    [Abstract] [Full Text] [Related]

  • 11. The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorodeoxyglucose positron emission tomographic imaging in patients with prior infarction and left ventricular dysfunction.
    Go RT, MacIntyre WJ, Cook SA, Neumann DR, Brunken RC, Saha GB, Underwood DA, Marwick TH, Chen EQ, King JL, Khandekar S.
    J Nucl Cardiol; 1996 Sep 15; 3(2):96-104. PubMed ID: 8799234
    [Abstract] [Full Text] [Related]

  • 12. Myocardial viability assessed with fluorodeoxyglucose and PET in patients with Q wave myocardial infarction receiving thrombolysis: relationship to coronary anatomy and ventricular function.
    Fragasso G, Chierchia SL, Rossetti E, Sciammarella MG, Conversano A, Lucignani G, Landoni C, Calori G, Margonato A, Fazio F.
    Nucl Med Commun; 1997 Mar 15; 18(3):191-9. PubMed ID: 9106772
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metabolism and blood flow as new markers of myocardial viability in the evolution of myocardial infarction.
    Schwaiger M.
    Eur J Nucl Med; 1986 Mar 15; 12 Suppl():S62-5. PubMed ID: 3490380
    [Abstract] [Full Text] [Related]

  • 18. Automated interstudy image registration technique for SPECT and PET.
    Eberl S, Kanno I, Fulton RR, Ryan A, Hutton BF, Fulham MJ.
    J Nucl Med; 1996 Jan 15; 37(1):137-45. PubMed ID: 8543983
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies.
    Choi Y, Hawkins RA, Huang SC, Gambhir SS, Brunken RC, Phelps ME, Schelbert HR.
    J Nucl Med; 1991 Apr 15; 32(4):733-8. PubMed ID: 2013815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.